Ventus Therapeutics to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)-- Ventus Therapeutics, a leading Phase 2 clinical-stage biopharmaceutical company advancing two novel small-molecule programs for immunological, inflammatory, and neurological disorders, today announced that its President and Chief Executive Officer, Marcelo Bigal, M.D., Ph.D., will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference, being held May 5-6 in Toronto. Dr. Bigal will be presenting on Tuesday, May 6, at 1:30 p.m. ET.
About Ventus Therapeutics
Ventus Therapeutics is a leading Phase 2 clinical-stage biopharmaceutical company advancing two novel small-molecule programs for immunological, inflammatory, and neurological disorders. Using its proprietary drug discovery platform, ReSOLVE ®, the company has established a robust pipeline, including two wholly-owned programs. VENT-03 is a first-in-class, oral cGAS inhibitor expected to enter Phase 2 development for lupus in 2025. VENT-02 is a best-in-class, brain-penetrant, oral NLRP3 inhibitor in Phase 2 for Parkinson's disease, and is expected to enter Phase 2 development for osteoarthritis in obese patients later in 2025. In addition, Ventus has out-licensed VENT-01, a peripherally-restricted, oral NLRP3 inhibitor in Phase 1, to Novo Nordisk A/S. For more information, please visit www.ventustx.com and engage with Ventus on LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
42 minutes ago
- Business Upturn
Lupin gets U.S. FDA tentative approval for Generic Oxcarbazepine ER Tablets
Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Oxcarbazepine Extended-Release (ER) Tablets in 150 mg, 300 mg, and 600 mg strengths. These tablets are the generic equivalent of Oxtellar XR® ER Tablets by Supernus Pharmaceuticals and are indicated for the treatment of partial-onset seizures in patients aged 6 years and above. Lupin's version of the drug will be manufactured at its Nagpur facility in India. According to IQVIA MAT April 2025 data, Oxcarbazepine ER Tablets (RLD Oxtellar XR®) recorded estimated annual sales of USD 206 million in the United States, underscoring the potential market opportunity for Lupin. Headquartered in Mumbai, Lupin is a leading global pharmaceutical company with a strong footprint in the U.S. and India. The company focuses on a broad range of therapy areas including central nervous system disorders, respiratory, cardiovascular, anti-infective, and women's health. It operates 15 manufacturing sites and 7 research centers globally, supported by over 23,000 employees. Lupin continues to expand its U.S. portfolio of complex generics and remains committed to delivering high-quality, affordable medicines that improve health outcomes for patients around the world. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
an hour ago
- Yahoo
I just financed a car for $15,000 at 14.89% APR — but then got a call saying my rate is now 15%. What do I do?
Financing a car at a high interest rate can be frustrating, but what's even worse is being promised a specific rate through the car dealer and then being stuck with a different one. Thanks to Jeff Bezos, you can now become a landlord for as little as $100 — and no, you don't have to deal with tenants or fix freezers. Here's how I'm 49 years old and have nothing saved for retirement — what should I do? Don't panic. Here are 6 of the easiest ways you can catch up (and fast) Nervous about the stock market in 2025? Find out how you can access this $1B private real estate fund (with as little as $10) It's called yo-yo financing, a deceptive tactic used by auto dealers that allows you to drive the car off the lot before the financing is fully finalized. You are then informed that the loan fell through and that you must accept less favorable terms to complete the purchase. You might have regrets about taking out a $15,000 car loan with a 14.89% annual percentage rate (APR). But it looks like your APR is even higher and you need to re-sign the documents? Should you proceed, or use this opportunity to get out of the loan? The average user car loan rate was 11.87% in Q1 2025, according to Experian. However, the average for customers with Deep subprime (credit scores 300 to 500) and Subprime (credit scores of 501 to 600) credit was 21.58% and 18.99%, respectively. Considering you say you have bad credit, the rate you were offered at the start (14.89%) isn't surprising. However, it doesn't mean you made a smart financial decision with this purchase. More on that later. Now it seems the actual rate has come through at 15%, which means the dealership may be engaging in yo-yo financing. Or, it could just be a case of poor communication. Usually, with yo-yo financing, there's a substantial difference between the original APR offered and the one a dealer tries to stick you with. Here, the difference here isn't so tremendous. Also, dealers commonly use yo-yo financing to lure buyers with super low rates. A 14.89% APR isn't that competitive. Review the paperwork you signed. It could be that it says the sale is not final and the dealer can change the terms. In this case, you would have to resign the documents with the new APR to keep the car. You probably also have the right to give back the car instead of paying a 15% APR on your loan. This could actually be a great opportunity to get out of a bad deal that could hurt you financially. It may be time to give back the car and consider other options, like saving up for a car you can pay in cash for or saving to pay a larger down payment. You don't want to be stuck making payments for a car that you can't afford, and a 14.89% rate is quite high. If you're committed to keeping the car, you'll have to decide if it's worth paying the slightly higher rate. You may be able to refinance later. You can also find alternative financing for the car instead of going through the dealer. If you shop around, you may secure a lower APR. Read more: Want an extra $1,300,000 when you retire? Dave Ramsey says — and that 'anyone' can do it A lower APR means lower interest costs and monthly payments. So, always do what you can to secure the lowest rate possible. One of the best ways to do this is by boosting your credit score. According to Experian, the average used car loan rate for Prime (credit scores of 661 to 780) and Super-prime (credit scores of 781 to 850) buyers was 9.06% and 6.82%, respectively. 'There's no minimum credit score required to get an auto loan. However, a credit score of 661 or above … will generally improve your chances of getting approved with favorable terms,' says the credit bureau. To boost your credit score, aim to pay all debts on time and try to keep your credit utilization as low as possible. Credit utilization is the percentage of total available credit that you're currently using, and is a key credit score factor. Paying down credit card debt can improve your utilization. It's also important to check your credit report regularly for mistakes. You can request a free copy every week here. Also, shop around when you're taking out an auto loan, and don't assume your dealership has the best rate to offer. Financing an auto loan through your dealership may be convenient, but you're probably better off reaching out to banks and credit unions to see what rates they offer. A good place to start is with a bank or credit union you already have a relationship with. Choosing a shorter auto loan term can lower your interest costs, assuming you can get the same interest rate or better. You'll have a higher monthly payment, but you should pay less interest by paying off your car loan more quickly. Finally, you can also save on interest by taking out a smaller loan, by providing a larger down payment up front, or purchasing a more affordable vehicle. Rich, young Americans are ditching the stormy stock market — here are the alternative assets they're banking on instead How much cash do you plan to keep on hand after you retire? Here are 3 of the biggest reasons you'll need a substantial stash of savings in retirement Robert Kiyosaki warns of a 'Greater Depression' coming to the US — with millions of Americans going poor. But he says these 2 'easy-money' assets will bring in 'great wealth'. How to get in now Here are 5 'must have' items that Americans (almost) always overpay for — and very quickly regret. How many are hurting you? Like what you read? Join 200,000+ readers and get the best of Moneywise straight to your inbox every week. This article provides information only and should not be construed as advice. It is provided without warranty of any kind. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
BP overhauling TA's marketing department
This story was originally published on C-Store Dive. To receive daily news and insights, subscribe to our free daily C-Store Dive newsletter. BP is making changes to TravelCenters of America's marketing department that will result in layoffs through the rest of 2025, a company spokesperson confirmed to C-Store Dive. The changes are part of BP's ongoing strategy reset, which launched earlier this year to improve the company's performance, drive cash flow and increase shareholder value, the spokesperson said. They did not share how many team members are expected to be impacted. This comes about five months after BP revealed plans to cut about 5% of its global workforce by 2026. At the time, a BP spokesperson declined to share specifics on the company divisions and regions impacted by the layoffs.. In a memo sent to BP's employees back in January, CEO Murray Auchincloss said the 5% workforce reduction aimed to help the oil giant position itself as a 'simpler, more focused' company. That still appears to be the case with the latest changes at TA, as a source familiar with the matter said the latest moves aim to unify all marketing functions under the BP umbrella. This source added that some employees from TA's marketing team remain with the company, but they're now employed by BP instead of TA. In a statement to C-Store Dive, BP's spokesperson said the company is overhauling its marketing functions to help its businesses and brands be more successful and improve connections with customers. 'In February 2025 we proposed changes to our marketing organization and how we work, and as a result, this will impact roles across our marketing teams through 2025, including in TravelCenters of America,' BP's spokesperson said. BP acquired TA in May 2023. The acquisition, which included TA's 300 travel centers and 20,000 employees, 'fundamentally changed' BP's U.S. footprint, the oil giant said in its 2024 annual report. It's unclear how many of those 20,000 team members were in marketing. Recommended Reading BP to cut about 5% of global workforce
